Bristol-Myers Beats 3Q Forecasts as Top Drugs Deliver
October 24, 2014 at 08:33 AM EDT
Bristol-Myers Squibb Co reported better-than-expected third-quarter results, fueled by strong sales of its treatments for blood clots, cancer and arthritis.
